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The expression of adenovirus late genes is shown to require viral DNA replication, but its mechanism
remains elusive. Here we found that knockdown of CTCF suppresses viral DNA replication as well as late,
but not early, gene expression. Chromatin immunoprecipitation assays indicated that CTCF binds to viral
chromatin depending on viral DNA replication. These findings depict CTCF as a critical regulator for
adenovirus genome functions in late phases of infection.
I
n the cell nucleus, the genomic DNA forms chromatin structure. It is being clarified that the higher-order
chromatin structure, such as the DNA looping, plays an important role in a dynamic property of the chro-
matin1. One of the chromatin organizing proteins, CTCF (CCCTC-binding factor), is a well-characterized
chromatin-binding factor involved in the formation of the long-range interactions of chromatin2. CTCF has
eleven zinc fingers and therefore binds to divergent DNA sequences, as indicated by chromatin immunopreci-
pitation (ChIP) in combination with tiling arrays (ChIP-on-chip)3 or high-throughput sequencing analyses
(ChIP-seq)4. A variety of chromatin-related proteins are reported as binding partners of CTCF, including cohesin
complexes5,6, a nucleolar protein B23/nucleophosmin, and CTCF itself 7. These interactions are thought to enable
CTCF binding sites to contact each other and/or be tethered to the subnuclear domains, resulting in the formation
of intra- and interchromatin interaction2. In addition to the role on the cellular chromatin, recent reports have
revealed the involvement of CTCF on viral proliferation, as Lieberman and co-workers recently demonstrated the
CTCF-mediated formation of chromatin loops on Kaposi’s sarcoma-associated Herpesvirus (KSHV) and
Epstein-Barr virus (EBV) genomes8,9. It is shown that CTCF regulates the latency-specific chromatin conforma-
tion of KSHV and EBV genomes, and siRNA-mediated depletion of CTCF or mutations in the CTCF binding
sites disrupt the chromatin architecture and de-regulate latent gene expression8,9. Thus, CTCF could impact on
the regulation of not only cellular but also viral chromatin.
The adenovirus (Ad) has a linear double-stranded DNA genome that forms chromatin-like structure in the
virion10. Previously, we have reported that viral chromatin structure regulates the expression of viral early genes
(e.g. E1A, E4 genes) in early phases of infection11,12. The expression of the late genes (e.g. major late genes) are
hardly observed during early phases of infection, while concomitantly with the onset of viral DNA replication,
those genes are fully activated. Thomas and Mathews demonstrated that the expression of the late genes requires
viral DNA replication in cis13. In addition, we have shown the regulatory mechanism of the viral chromatin
structure during DNA replication and proposed a possible role of viral DNA replication in the activation of late
genes14. Thus, it is suggested that the regulation of viral chromatin structure has a significant role in the DNA
replication-dependent activation of viral genes. In spite of these evidences, however, the functional relationship
between viral gene expression and DNA replication in infected cells remains largely unclear. In this study we
sought to further clarify the role of chromatin structure and/or chromatin-related factors on the Ad genome
DNA. As described above, it is shown that CTCF plays a role on the chromatin of someDNAviruses8,9. These lead
us to hypothesize that CTCF could function also on Ad chromatin.
Results
CTCF is required for viral DNA replication and late gene expression. To study a role of CTCF, we carried out
knock down (KD) of the expression of CTCF by siRNA treatment (Fig. 1A). Either control siRNA (siCont) or
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siRNA targeted for CTCF (siCTCF) was introduced into HeLa cells,
and then cell lysates were prepared and subjected to western blot
analyses using anti-CTCF antibody. Only a single band corre-
sponding to CTCF was detected, demonstrating the specificity of
the antibody. Under our experimental condition, the expression
level of CTCF in siCTCF-treated cells was decreased to appro-
ximately 25% of that in control cells (Fig. 1A, compare lane 4 with
lanes 1–3).
To test whether CTCF plays a role in Ad DNA replication and
gene expression, we carried out CTCF KD followed by quantitative
PCR (qPCR) of viral DNA and RT-qPCR (Fig. 1B and C). Under our
experimental condition, the onset of viral DNA replication can be
observed around 8 hpi (hours post infection)12,14. siCont- or siCTCF-
treated cells were mock-infected or infected with human adenovirus
type 5 (HAdV5) at anMOI (multiplicity of infection) of 100, and at 6
(for early phases) and 12 hpi (for late phases of infection) total DNAs
and RNAs were purified. We first measured viral DNA amounts by
qPCR using a primer set targeted for the E1A promoter region (E1A
pro, see Table 2) to evaluate the efficiency of viral DNA replication
(Fig. 1B). In siCont-treated cells, the amount of viral DNA was in-
creased by ,30 fold through viral DNA replication. In contrast,
siCTCF-treated cells allowed only,9 fold amplification of viral DNA.
Next, we performed RT-qPCR assays using several primer sets for
cellular and viral genes (Fig. 1C). Under the condition employed
here, the mRNA level of GAPDH was unaffected by Ad infection
and siRNA treatment, and that ofCTCFwas specifically decreased by
siCTCF treatment (Fig. 1C,GAPDH andCTCF). ThemRNA levels of
viral early genes were not significantly affected byCTCFKD (Fig. 1C,
E1A and E4), suggesting that CTCF is not involved in viral early gene
expression. In contrast, the level of mRNA transcribed from the
major late promoter (MLP) was drastically decreased by siCTCF
treatment (Fig. 1C, MLP). Similarly, the mRNA level of E2A was
reduced by CTCF KD, particularly at 12 hpi (Fig. 1C, E2A). It is
noted that E2 gene transcription is regulated by early and late pro-
moters and transcription from the E2 late promoter depends on viral
DNA replication15 (Unpublished data). Therefore, it is reasonable to
assume that CTCF KD could predominantly affect the transcription
from the E2 late promoter, although in this study we did not dis-
criminate E2A mRNAs transcribed from two promoters. Collec-
tively, these results suggest that CTCF is critical for viral DNA
replication as well as late, but not early, gene expression.
CTCF binds to viral chromatin in a DNA replication-dependent
manner. To examine whether CTCF functions directly on viral
chromatin, ChIP assays were performed using anti-CTCF antibody
(Fig. 2). Since the effect of CTCF KD was observed in late phases of
infection (Fig. 1), first we studied using infected cells at 12 hpi for
ChIP assays (Fig. 2A). We used a variety of primer sets for the Ad
genome to test the genome-wide binding of CTCF (see Fig. 2B). We
found that CTCF is recruited into several regions of the virus
genome, including the MLP region and the ORF regions of the
viral structural protein (Hexon) and the E4 ORF3 gene (E4 orf). In
addition, a weak binding of CTCF at the E1A pro region was
observed. Next, we focused on three CTCF binding sites, the E1A
pro,MLP, andHexon regions, and performed ChIP assays using cells
cultured in the absence or presence of hydroxyurea (HU), a DNA
replication inhibitor, to examine whether the CTCF binding ob-
served here is DNA replication-dependent (Fig. 2C). The recruit-
ment of CTCF into those regions was observed only at 12 hpi, and
this was inhibited by the addition of HU, indicating that CTCF is
recruited onto viral chromatin in a DNA replication-dependent
manner.
Discussion
The results obtained in this study indicate that CTCF binds to Ad
chromatin depending on its DNA replication and plays a pivotal role
in late phases of infection. Our KD experiments clearly reveal that
CTCF is required for viral DNA replication and late gene expression
(Fig. 1B and C). It is demonstrated that viral late genes are activated
depending on its DNA replication13. Thus, the mRNA levels of late
genes also should be affected when only DNA replication would be
directly repressed by CTCF KD. Conversely, viral factors involved in
Figure 1 | Effects of CTCF KD on viral DNA replication and gene expression. (A) Western blotting and knockdown of CTCF. Cell lysates were
prepared from HeLa cells treated with siCont (lanes 3) or siCTCF (lane 4) and subjected to western blot analyses using anti-CTCF (top panel) and
anti-b-actin antibodies (bottom panel). For siCont-treated cells, 25% (lane 1) and 50% (lane 2) volume of lysates were also loaded. Full-size images are
shown in Supplementary figure 1. (B) Amounts of viral DNA. HeLa cells treated with siCont or siCTCF were infected with HAdV5 at anMOI of 100, and
total DNAs were purified at 6 and 12 hpi. The amount of viral DNA was measured by qPCR using primers for the E1A promoter. The amount at 12 hpi
relative to that at 6 hpi was graphed. Mean values with s.d. were obtained from three independent experiments. (C) RT-qPCR assays. Total RNAs
were purified at 6 and 12 hpi, and subjected to RT-qPCR using indicated primer sets. The mRNA levels relative to those of control cells at 12 hpi were
graphed. Mean values with s.d. were obtained from three independent experiments. P-values are calculated using Student’s t-test. ‘‘n.s.’’ indicates ‘‘not
statistically significant’’.
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its DNA replication are encoded by the E2 gene, and its expression
was suppressed by CTCF KD (Fig. 1C). Therefore, the inhibition of
viral late gene expression also could be the cause for less efficient viral
DNA replication. Because of this interdependency, we could not
precisely discriminate whether CTCF KD primarily affects viral
DNA replication or late gene expression (or both). In addition, we
could not exclude the possibility that the lower level of the MLP
mRNA in siCTCF-treated cells results from less amount of viral
DNA templates due to the defect in viral DNA replication.
Nonetheless, we speculate that CTCF may be involved in the regu-
lation of late gene expression: First, the binding of CTCF is depend-
ent on viral DNA replication (Fig. 2C), suggesting that this protein
possibly functions in the step(s) later than viral DNA replication;
second, when the level of the MLP mRNA at 12 hpi was normalized
by the amounts of the virus genome, the level of the MLPmRNA per
one viral DNA in CTCF KD cells was still lower than that in control
cells (Fig. 1, MLP mRNA level:,15%/virus genome:,30%5MLP
mRNA per one viral DNA: ,50%).
It is an important question howCTCF regulates the function of the
virus genome/chromatin. Although in this study we found several
CTCF binding sites (Fig. 2A), there could be additional regions for
CTCF on the virus genome. Thus, at the moment, it is difficult to
dissect a role of each CTCF binding site and the cooperative function
among those regions. It is suggested that the E1B, IX, and E2 late
genes/promoters are also activated depending on viral DNA replica-
tion15–17 as is the MLP. However, we could not observe the CTCF
binding on those regions (Fig. 2A), suggesting that the recruitment of
CTCF onto each late promoter seems not to be required for the
genome-wide coordination between viral DNA replication and the
expression of late genes. Further studies are needed to address these
points. As described above, it is shown that Ad DNA replication is
required for the activation of viral late genes13. Similarly it is reported
that DNA replication is essential for the expression of certain cellular
genes such as theHoxB gene18, although themolecular details remain
to be determined. To our knowledge, this is the first report indicating
the possible involvement of CTCF in the DNA replication-depend-
ent activation of the genes. Thus, our findings may provide insight
into an uncharacterized mechanism of gene regulation that involves
DNA replication.
Methods
Cells and viruses. Maintenance of HeLa cells, and purification and infection of
human adenovirus type 5 (HAdV5) were carried out essentially as described
previously12,14. Hydroxyurea (HU)was added at the final concentration of 2 mMright
after infection to block DNA replication.
Antibodies. To obtain recombinant CTCF N-terminal region (amino acids (aa)
1–267) as an antigen, the expression vector for His-tagged CTCF(1–267) was
constructed. cDNA fragment of full-length CTCF was amplified by PCR with a
primer set, 59-AGGGCATATGGAAGGTGATGCAGTCGAAGCCATTGTGG-3’
and 59-AGCCTCGAGAAGTCCTGGCGACGCACAAGGCTCCGCC-3’, and
cloned into the pBluescript-FLAG vector (pBS-FLAG-CTCF). Using pBS-FLAG-
CTCF as a template, cDNA fragment corresponding to aa 1-267 was amplified by
PCR with a primer set, 59-AGGGCATATGGAAGGTGATGCAGTCGAAG-
CCATTGTGG-3’ and 59-GTTGAATTCACTGGAATGTCTTCTTTACAC-39, and
cloned into the pET-14b vector. E. coli was transformed with the resultant vector,
pET-14b-CTCF(1-267), and His-CTCF(1–267) was expressed and purified using the
Ni-NTA resin (Novagen) according to the manufacturer’s protocol.
Rabbit anti-CTCF antibody was raised against His-CTCF(1–267) according to
standard protocols. Mouse anti-FLAG M2 and mouse anti-b-actin antibodies were
described elsewhere12,14.
RT-qPCR assays. RT-PCR and quantitative PCR (qPCR) were performed essentially
as described previously12,14. Total RNAs were purified by phenol extraction followed
by DNase I treatment. cDNA was synthesized from total RNA (1 mg) using
ReverTraAce (Toyobo) and oligo-dT primer according to the manufacturer’s
protocol. qPCR was carried out using FastStart SYBR Green Master (Roche) and
Figure 2 | CTCF binding on viral chromatin. (A) ChIP assays with anti-CTCF antibody. HeLa cells were infected with HAdV5 at an MOI of 100,
and at 12 hpi subjected to ChIP assays using anti-CTCF and anti-FLAG antibodies. The binding levels were calculated as fold enrichment against that
obtained in a negative control (anti-FLAG antibody). Mean values with s.d. were obtained from three independent experiments. (B) Structure of the Ad
genome. Arrows represent promoters of viral genes. Target regions for ChIP assays are indicated by gray bars. (C) Effect of viral DNA replication on
CTCF binding. HeLa cells were infected with HAdV5 and cultured in the absence or presence of 2 mMHU. At 6 and 12 hpi, ChIP assays were carried out
as described above. P-values are calculated using Student’s t-test.
Table 1 | Primers used for RT-qPCR
Primer Sequence (59-39)
GAPDH forward AGCCAAAAGGGTCATCATCTC
GAPDH reverse GGACTGTGGTCATGAGTCCTTC
CTCF forward TGACACAGTCATAGCCCGAAAA
CTCF reverse TGCCTTGCTCAATATAGGAATGC
E1A forward GAGACATATTATCTGCCACGGAG
E1A reverse AGTGAGTAAGTCAATCCCTTCCTG
E4 forward ACAGAACCCTAGTATTCAACCTGC
E4 reverse GACAGCGACATGAACTTAAGTGAG
MLP forward ACTCTCTTCCGCATCGCTGT
MLP reverse GTGACTGGTTAGACGCCTTTCT
E2A forward GTGTAGACACTTAAGCTCGCCTT
E2A reverse CTTCAAACTACTGCCTGACCAAGT
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Thermal Cycler Dice Real Time System (Takara) according to the manufacturers’
protocol.
Table 1 indicates primer sequences for GAPDH, CTCF, E1A, E4, MLP, and E2A
genes.
ChIP assays.ChIP assays were carried out according to the protocol fromChromatin
Immunoprecipitation Assay Kit (Millipore) with minor modification, essentially as
described previously12,14. Briefly, cells were fixed with 1% formaldehyde, followed by
the addition of glycine at the final concentration of 125 mM for quenching. After
centrifugation, cell pellets were lysed with SDS lysis buffer (50 mM Tris-HCl [pH
7.9], 10 mM EDTA, and 1% SDS), and lysates were subjected to sonication to shear
the chromatin DNA to ,1 kbp in size. Sonicated samples were diluted 10 fold with
ChIP dilution buffer (16.7 mM Tris-HCl [pH 7.9], 1.2 mM EDTA, 167 mM NaCl,
1.1% Triton X-100, and 0.01% SDS) and then pre-cleared with Protein A Sepharose 4
Fast Flow (GEHealthcare). An antibodywas added to the pre-cleared sample solution
and incubated overnight at 4uC. Antibody-protein-DNA complexes were incubated
with Protein A Sepharose at 4uC for 1 hr, and then the beads were washed with Low
Salt Wash Buffer (20 mM Tris-HCl [pH 7.9], 2 mM EDTA, 150 mM NaCl, 1%
Triton X-100, and 0.1% SDS), High Salt Wash Buffer (20 mM Tris-HCl [pH 7.9],
2 mM EDTA, 500 mM NaCl, 1% Triton X-100, and 0.1% SDS), LiCl Wash Buffer
(10 mM Tris-HCl [pH 7.9], 1 mM EDTA, 0.25 M LiCl, 1% NP-40, and 1%
deoxycholic acid), and TE (10 mM Tris-HCl [pH 7.9] and 1 mM EDTA)
successively. Protein-DNA complexes were eluted from the beads with elution buffer
(1% SDS, 100 mM NaHCO3, and 10 mM DTT), and crosslinking was reversed by
incubation at 65uC for 4 hr. After treatment with Proteinase K, DNAs were recovered
by phenol/chloroform extraction and ethanol precipitation. Obtained DNA samples
were subjected to qPCR as described above.
Table 2 shows primer sequences for 59 inverted terminal region (59 ITR), the E1A
enhancer (E1A enh), the E1A promoter (E1A pro), the E1A coding region (E1A cds),
the E1A 39 region (E1A 39), the E1B promoter (E1B pro), the IX promoter (IX pro),
the ML promoter (MLP), the VA I gene (VA I), the Hexon ORF (Hexon), the E2B
ORF (E2B orf), the E2 late promoter (E2late pro), the E3 promoter (E3 pro), the E4
ORF3 (E4 orf), and the E4 promoter regions (E4 pro).
siRNA-mediated knockdown, quantification of viral DNA, and western blot
assays. These experiments were carried out essentially as described previously12,14,19.
siRNA targeted for CTCF was commercially purchased (Stealth siRNA; Invitrogen).
siRNAs were introduced into cells with Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s protocol. Total DNAs were purified by treatment with Proteinase
K, followed by phenol/chloroform extraction and ethanol precipitation, as described
previously19. Quantitative determination of viral DNA was carried out by qPCR as
described above. For western blot analyses, cell lysates were subjected to SDS-PAGE,
and proteins were transferred to a PVDFmembrane (Millipore). The membrane was
incubated with primary antibodies, followed by incubationwith secondary antibodies
conjugated with horseradish peroxidase (GE Healthcare). The blot was developed
using Chemi-Lumi One (Nacalai tesque).
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